openPR Logo
Press release

Bardet-Biedl Syndrome Diagnostics Market Demonstrates Significant CAGR, Forecast Period 2024-2031 | Invitae Corporation, Blueprint Genetics Oy, Prevention Genetics

11-04-2025 01:24 PM CET | Health & Medicine

Press release from: DataM Intelligence 4market Research LLP

Bardet-Biedl Syndrome Diagnostics Market

Bardet-Biedl Syndrome Diagnostics Market

Bardet-Biedl Syndrome Diagnostics Market is valued at a significant CAGR during the forecast period (2024-2031). As per DataM Intelligence Database.

The Bardet-Biedl Syndrome (BBS) Diagnostics Market focuses on tools and technologies used to identify Bardet-Biedl Syndrome, a rare genetic disorder affecting multiple organ systems, including vision, kidneys, and metabolism. Diagnostic methods typically include genetic testing, molecular analysis, and clinical evaluations to detect mutations in BBS-related genes. The market is growing due to increasing awareness of rare diseases, advancements in next-generation sequencing (NGS), and government initiatives supporting early diagnosis. Moreover, the rising integration of AI-driven genetic analysis and precision medicine is enhancing diagnostic accuracy and patient management in BBS cases.

πŸ“Œ Download Sample Report to Identify Emerging Deals & Opportunities in the Bardet-Biedl Syndrome Diagnostics Market Landscape:- https://datamintelligence.com/download-sample/bardet-biedl-syndrome-diagnostics-market?Ranjith

β˜› Bardet-Biedl Syndrome Diagnostics Market Recent Developments 2025:

United States: Recent Industry Developments

βœ… In September 2025, PreventionGenetics (a part of Exact Sciences) expanded its rare genetic testing portfolio to include a comprehensive Bardet-Biedl Syndrome (BBS) diagnostic panel analyzing over 20 BBS-related genes using next-generation sequencing (NGS) for improved diagnostic accuracy.

βœ… In August 2025, Invitae Corporation launched an updated BBS genetic testing service integrated with AI-driven variant interpretation tools, enabling faster and more precise identification of pathogenic mutations in suspected BBS patients.

βœ… In July 2025, PerkinElmer Genomics collaborated with the National Institutes of Health (NIH) to enhance whole-exome sequencing programs for early detection of BBS and other ciliopathies through population-scale screening initiatives.

βœ… In June 2025, GeneDx (BioReference Health) introduced a rapid exome-based diagnostic test tailored for pediatric cases of BBS, significantly reducing turnaround time for clinical decision-making and personalized treatment planning.

Japan: Recent Industry Developments
βœ… In September 2025, Sysmex Corporation launched a next-generation sequencing workflow for rare disease diagnostics, including Bardet-Biedl Syndrome, aimed at supporting precision medicine efforts in national health institutions.

βœ… In August 2025, Riken Genomic Sciences Center initiated a nationwide genetic screening project focusing on ciliopathies such as BBS to improve early diagnosis and genetic counseling accessibility.

βœ… In July 2025, Tohoku University Hospital introduced a clinical gene panel test for BBS using hybrid-capture sequencing, allowing simultaneous analysis of multiple genes implicated in retinal dystrophy and obesity syndromes.

βœ… In June 2025, Takara Bio Inc. developed a customized BBS gene enrichment kit to support academic and clinical research, accelerating variant detection and genotype-phenotype correlation studies in Japanese populations.

β˜› Bardet-Biedl Syndrome Diagnostics Market Competitive Landscape:

Invitae Corporation, Blueprint Genetics Oy, Prevention Genetics, Fulgent Genetics, Paragon Genomics, Inc., Igenomix, CD Genomics, Redcliffe labs, Asper Biogene and Mikrogenlab among others.

Research Methodology

We follow a hybrid research approach, combining qualitative insights with rigorous quantitative analysis to deliver reliable and comprehensive market intelligence. Our process begins with extensive secondary research, drawing on trusted industry reports, proprietary databases, and credible market sources. This is then reinforced through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.

πŸ“Œ Request a Customized Market Report - Tailored insights to match your business goals: https://datamintelligence.com/customize/bardet-biedl-syndrome-diagnostics-market?Ranjith

β˜› Segments Covered in the Bardet-Biedl Syndrome Diagnostics Market:

By Test Type:
Biochemical Testing | Genetic Testing | Electroretinography (ERG) | Others

By Technology:
Next-Generation Sequencing (NGS) | Polymerase Chain Reaction (PCR) | Arrayed Primer Extension (APEX) | Whole Genome Sequencing | Others

By End-User:
Hospitals | Diagnostic Centers | Homecare | Others

β˜› This Report Includes:

βœ” Comprehensive go-to-market strategies with actionable insights.

βœ” Unbiased evaluation of overall market performance.

βœ” Deep-dive analysis into development trends, competitive landscape, supply-demand dynamics, YoY growth, benchmarking, vendor mapping, market access, and overall progress.

βœ” Tailored regional and country-level reports with detailed localized analysis available on request.

βœ” Identification of niche segments and high-growth regions presenting strong opportunities.

βœ” Accurate regional forecasts using both top-down and bottom-up approaches.

πŸ“Œ Get Corporate Access to Live Bardet-Biedl Syndrome Diagnostics Industry Intelligence Database: https://www.datamintelligence.com/buy-now-page?report=bardet-biedl-syndrome-diagnostics-market?Ranjith

β˜› Regional Analysis for Bardet-Biedl Syndrome Diagnostics Market:

β‡₯ North America (U.S., Canada, Mexico)

β‡₯ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

β‡₯ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

β‡₯ South America (Colombia, Brazil, Argentina, Rest of South America)

β‡₯ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

πŸ“Œ Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

β˜› Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

βœ… Competitive Landscape
βœ… Sustainability Impact Analysis
βœ… KOL / Stakeholder Insights
βœ… Unmet Needs & Positioning, Pricing & Market Access Snapshots
βœ… Market Volatility & Emerging Risks Analysis
βœ… Quarterly Industry Report Updated
βœ… Live Market & Pricing Trends
βœ… Import-Export Data Monitoring

β˜› Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bardet-Biedl Syndrome Diagnostics Market Demonstrates Significant CAGR, Forecast Period 2024-2031 | Invitae Corporation, Blueprint Genetics Oy, Prevention Genetics here

News-ID: 4253276 • Views: …

More Releases from DataM Intelligence 4market Research LLP

United States Fiberboard Market to Reach US$53.8 Billion by 2031, Driven by Construction & Furniture Demand
United States Fiberboard Market to Reach US$53.8 Billion by 2031, Driven by Cons …
Global Fiberboard Market reached US$ 24.9 billion in 2022 and is expected to reach US$ 53.8 billion by 2031, growing with a CAGR of 7.8% during the forecast period 2024-2031. The Fiberboard Market includes engineered wood products made from wood fibers, used in furniture, construction, and flooring. Growth is driven by cost-effective manufacturing, urbanization, and increasing interior design applications. MDF and HDF boards dominate the market. Advancements in resin technologies improve…
Feed Packaging Market reached US$ 13.20 billion in 2022 and is expected to reach US$ 20.72 billion by 2031 | LC Packaging, Mondi, Amcor plc.
Feed Packaging Market reached US$ 13.20 billion in 2022 and is expected to reach …
Global Feed Packaging Market reached US$ 13.20 billion in 2022 and is expected to reach US$ 20.72 billion by 2031, growing with a CAGR of 5.8% during the forecast period 2024-2031. The Feed Packaging Market focuses on the development and use of durable, sustainable, and efficient packaging solutions for animal feed products, including dry, wet, and pet treats. It plays a crucial role in maintaining feed quality, preventing contamination, and extending…
Japan Plastic Straps Market to Hit US$ 9.4 Billion by 2031, Fueled by 14.42% CAGR and Green Packaging Innovations
Japan Plastic Straps Market to Hit US$ 9.4 Billion by 2031, Fueled by 14.42% CAG …
The Plastic Straps Market was valued at US$ 3.2 billion in 2023 and is projected to reach US$ 9.4 billion by 2031, expanding at a CAGR of 14.42% during the forecast period 2024-2031. Plastic straps are essential for secure packaging and bundling across industries like logistics, construction, and manufacturing. Market growth is fueled by expanding e-commerce, industrial demand, and the need for durable, cost-effective strapping solutions. ➠ Download Your Sample Report Instantly…
Acacia Fiber Powder Market reached US$ 821.32 million in 2022 and is expected to reach US$ 1250.94 million by 2031 | LATEST NEWS & Developments
Acacia Fiber Powder Market reached US$ 821.32 million in 2022 and is expected to …
Global Acacia Fiber Powder Market reached US$ 821.32 million in 2022 and is expected to reach US$ 1250.94 million by 2031, growing with a CAGR of 5.4% during the forecast period 2024-2031. The Acacia Fiber Powder Market includes natural prebiotic fibers derived from acacia gum, used in foods, supplements, and beverages. Growth is driven by digestive health awareness and rising demand for clean-label functional ingredients. Acacia fiber improves gut microbiota, supports…

All 5 Releases


More Releases for Syndrome

"Understanding Rett Syndrome: Trends and Advances in the Rett Syndrome Market"
The Rett Syndrome Market, valued at USD 225.02 million in 2022, is anticipated to surge to USD 515.06 million by 2029, reflecting a significant Compound Annual Growth Rate (CAGR) of 10.23% from 2023 to 2029. Overview of the Rett Syndrome Market: Rett syndrome, a rare genetic neurological and developmental disorder primarily impacting females, hinders brain development and causes progressive loss of motor skills and language. The market report underscores technological advancements…
MISME Syndrome Market - Navigating Challenges, Embracing Abilities: MISME Syndro …
Newark, New Castle, USA: The "MISME Syndrome Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. MISME Syndrome Market: https://www.growthplusreports.com/report/misme-syndrome-market/8883 This latest report researches the industry structure, sales, revenue,…
Felty Syndrome Market - A Dedicated Approach to Felty Syndrome Care and Empowerm …
Newark, New Castle, USA: The "Felty Syndrome Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Felty Syndrome Market: https://www.growthplusreports.com/report/felty-syndrome-market/8440 This latest report researches the industry structure, sales, revenue,…
MISME Syndrome Market - Transforming Lives: Empowering Recovery from MISME Syndr …
Newark, New Castle, USA - new report, titled MISME Syndrome Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the MISME Syndrome market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global MISME Syndrome market. The report offers an overview of the market, which…
Hepatorenal Syndrome Market - Reimagining Wellness, Redefining Survival: Hepator …
Newark, New Castle, USA - new report, titled Hepatorenal Syndrome Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Hepatorenal Syndrome market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Hepatorenal Syndrome market. The report offers an overview of the market, which…
Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syn …
Global Markets Directs, Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) - Pipeline Review, H2 2016, provides an overview of the Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and…